352 related articles for article (PubMed ID: 26809839)
1. Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.
Georgin-Lavialle S; Moura DS; Salvador A; Chauvet-Gelinier JC; Launay JM; Damaj G; Côté F; Soucié E; Chandesris MO; Barète S; Grandpeix-Guyodo C; Bachmeyer C; Alyanakian MA; Aouba A; Lortholary O; Dubreuil P; Teyssier JR; Trojak B; Haffen E; Vandel P; Bonin B; ; Hermine O; Gaillard R
Mol Psychiatry; 2016 Nov; 21(11):1511-1516. PubMed ID: 26809839
[TBL] [Abstract][Full Text] [Related]
2. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
[TBL] [Abstract][Full Text] [Related]
3. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
[TBL] [Abstract][Full Text] [Related]
4. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the tryptophan-kynurenine pathway and painful physical symptoms in patients with major depressive disorder.
Yun Y; Zhang Q; Zhao W; Ma T; Fan H; Bai L; Ma B; Qi S; Wang Z; An H; Yang F
J Psychosom Res; 2022 Dec; 163():111069. PubMed ID: 36335711
[TBL] [Abstract][Full Text] [Related]
6. Changes in tryptophan metabolism during pregnancy and postpartum periods: Potential involvement in postpartum depressive symptoms.
Teshigawara T; Mouri A; Kubo H; Nakamura Y; Shiino T; Okada T; Morikawa M; Nabeshima T; Ozaki N; Yamamoto Y; Saito K
J Affect Disord; 2019 Aug; 255():168-176. PubMed ID: 31158779
[TBL] [Abstract][Full Text] [Related]
7. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.
Miura H; Ozaki N; Sawada M; Isobe K; Ohta T; Nagatsu T
Stress; 2008 May; 11(3):198-209. PubMed ID: 18465467
[TBL] [Abstract][Full Text] [Related]
8. Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms.
Georgin-Lavialle S; Launay JM; Côté F; Soucié E; Soria A; Damaj G; Moura DS; Canioni D; Hanssens K; Chandesris MO; Barète S; Dubreuil P; Lortholary O; Hermine O; Sokol H
Allergy; 2016 Mar; 71(3):416-20. PubMed ID: 26841279
[TBL] [Abstract][Full Text] [Related]
9. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
[TBL] [Abstract][Full Text] [Related]
10. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
[TBL] [Abstract][Full Text] [Related]
11. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
Comai S; Cavalletto L; Chemello L; Bernardinello E; Ragazzi E; Costa CV; Bertazzo A
Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
[TBL] [Abstract][Full Text] [Related]
12. Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms.
Comai S; Nunez N; Atkin T; Ghabrash MF; Zakarian R; Fielding A; Saint-Laurent M; Low N; Sauber G; Ragazzi E; Hillard CJ; Gobbi G
BMC Med; 2024 Jan; 22(1):33. PubMed ID: 38273283
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine pathway changes in late-life depression.
Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
[TBL] [Abstract][Full Text] [Related]
14. Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus.
Anderson EW; Fishbein J; Hong J; Roeser J; Furie RA; Aranow C; Volpe BT; Diamond B; Mackay M
Lupus Sci Med; 2021 Oct; 8(1):. PubMed ID: 34686589
[TBL] [Abstract][Full Text] [Related]
15. [Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism].
Mouri A; Hasegawa M; Kunisawa K; Saito K; Nabeshima T
Nihon Yakurigaku Zasshi; 2023 May; 158(3):233-237. PubMed ID: 36990795
[TBL] [Abstract][Full Text] [Related]
16. Exercise and the Kynurenine pathway: Current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training.
Joisten N; Kummerhoff F; Koliamitra C; Schenk A; Walzik D; Hardt L; Knoop A; Thevis M; Kiesl D; Metcalfe AJ; Bloch W; Zimmer P
Exerc Immunol Rev; 2020; 26():24-42. PubMed ID: 32139353
[TBL] [Abstract][Full Text] [Related]
17. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
[TBL] [Abstract][Full Text] [Related]
18. The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis.
Almulla AF; Thipakorn Y; Vasupanrajit A; Tunvirachaisakul C; Oxenkrug G; Al-Hakeim HK; Maes M
Cells; 2022 Oct; 11(19):. PubMed ID: 36231075
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain.
Deng Y; Zhou M; Wang J; Yao J; Yu J; Liu W; Wu L; Wang J; Gao R
Gut Microbes; 2021; 13(1):1-16. PubMed ID: 33535879
[TBL] [Abstract][Full Text] [Related]
20. Peripheral and cerebral abnormalities of the tryptophan metabolism in the depression-like rats induced by chronic unpredicted mild stress.
Li CC; Jiang N; Gan L; Zhao MJ; Chang Q; Liu XM; Pan RL
Neurochem Int; 2020 Sep; 138():104771. PubMed ID: 32450184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]